Protein Design Labs regulatory update

PDLI received U.S. Patent No. 5,530,101 covering the Zenapax (Smart Anti-Tac) humanized antibody and other similar humanized antibodies that bind to a human interleukin-2 (IL-2) receptor. Partner Ro...